Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Te Chen

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
The Analyst|September 30, 2010
Rapid detection of two-protein interaction with a single fluorophore by using a microfluidic deviceChao-Kai Chou, Nan Jing, Hirohito Yamaguchi, et al.
Cancer Cell|January 11, 2011
EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signalingChun-Ju Chang, Jer-Yen Yang, Weiya Xia, et al.
Molecular and Cellular Biology|March 28, 2007
Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitizationQingqing Ding, Xianghuo He, Jung-Mao Hsu, et al.
Lab on a Chip|May 26, 2010
High speed digital protein interaction analysis using microfluidic single molecule detection systemChao-Kai Chou, Nan Jing, Hirohito Yamaguchi, et al.
Cancer Research|May 15, 2007
Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancerQingqing Ding, Xianghuo He, Weiya Xia, et al.
Nature Cell Biology|November 23, 2006
Tyrosine phosphorylation controls PCNA function through protein stabilityShao-Chun Wang, Yusuke Nakajima, Yung-Luen Yu, et al.
Cancer Research|January 7, 2006
Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cellsFu Ou-Yang, Keng-Li Lan, Chun-Te Chen, et al.
American Journal of Cancer Research|July 12, 2021
Glutamate-cysteine ligase catalytic subunit as a therapeutic target in acute myeloid leukemia and solid tumorsChiou-Hong Lin, John P Vu, Chen-Yen Yang, et al.
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
American Journal of Cancer Research|December 2, 2016
The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphomaHsu-Ping Kuo, Scott A Ezell, Sidney Hsieh, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
The Analyst|September 30, 2010
Rapid detection of two-protein interaction with a single fluorophore by using a microfluidic deviceChao-Kai Chou, Nan Jing, Hirohito Yamaguchi, et al.
Cancer Cell|January 11, 2011
EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signalingChun-Ju Chang, Jer-Yen Yang, Weiya Xia, et al.
Molecular and Cellular Biology|March 28, 2007
Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitizationQingqing Ding, Xianghuo He, Jung-Mao Hsu, et al.
Lab on a Chip|May 26, 2010
High speed digital protein interaction analysis using microfluidic single molecule detection systemChao-Kai Chou, Nan Jing, Hirohito Yamaguchi, et al.
Cancer Research|May 15, 2007
Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancerQingqing Ding, Xianghuo He, Weiya Xia, et al.
Nature Cell Biology|November 23, 2006
Tyrosine phosphorylation controls PCNA function through protein stabilityShao-Chun Wang, Yusuke Nakajima, Yung-Luen Yu, et al.
Cancer Research|January 7, 2006
Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cellsFu Ou-Yang, Keng-Li Lan, Chun-Te Chen, et al.
American Journal of Cancer Research|July 12, 2021
Glutamate-cysteine ligase catalytic subunit as a therapeutic target in acute myeloid leukemia and solid tumorsChiou-Hong Lin, John P Vu, Chen-Yen Yang, et al.
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
American Journal of Cancer Research|December 2, 2016
The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphomaHsu-Ping Kuo, Scott A Ezell, Sidney Hsieh, et al.
Pageof 4